1. Home
  2. CTM vs FLNA Comparison

CTM vs FLNA Comparison

Compare CTM & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

HOLD

Current Price

$0.54

Market Cap

63.1M

Sector

Technology

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

BUY

Current Price

$0.65

Market Cap

61.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CTM
FLNA
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
61.8M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
CTM
FLNA
Price
$0.54
$0.65
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
326.9K
★ 702.8K
Earning Date
11-06-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
★ N/A
N/A
Revenue
★ $52,866,001.00
$41,119,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.10
N/A
52 Week Low
$0.48
$0.64
52 Week High
$1.36
$2.03

Technical Indicators

Market Signals
Indicator
CTM
FLNA
Relative Strength Index (RSI) 32.73 34.93
Support Level $0.48 N/A
Resistance Level $0.66 $1.05
Average True Range (ATR) 0.02 0.04
MACD -0.01 -0.02
Stochastic Oscillator 27.14 3.74

Price Performance

Historical Comparison
CTM
FLNA

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: